Literature DB >> 11254580

Different regions of the malaria merozoite surface protein 1 of Plasmodium chabaudi elicit distinct T-cell and antibody isotype responses.

S J Quin1, J Langhorne.   

Abstract

In this study we have investigated the antibody and CD4 T-cell responses to the well-characterized malaria vaccine candidate MSP-1 during the course of a primary Plasmodium chabaudi chabaudi (AS) infection. Specific antibody responses can be detected within the first week of infection, and CD4 T cells can be detected after 3 weeks of infection. The magnitude of the CD4 T-cell response elicited during a primary infection depended upon the region of MSP-1. In general, the highest precursor frequencies were obtained when a recombinant MSP-1 fragment corresponding to amino acids 900 to 1507 was used as the antigen in vitro. By contrast, proliferative and cytokine responses against amino acids 1508 to 1766 containing the C-terminal 21-kDa region of the molecule were low. The characteristic interleukin 4 (IL-4) switch that occurs in the CD4 T-cell population after an acute blood stage P. c. chabaudi infection was only consistently observed in the response to the amino acid 900 to 1507 MSP1 fragment. A lower frequency of IL-4-producing cells was seen in response to other regions. Although the magnitudes of the immunoglobulin G antibody responses to the different regions of MSP-1 were similar, the isotype composition of each response was distinct, and there was no obvious relationship with the type of T helper cells generated. Interestingly, a relatively high antibody response to the C-terminal region of MSP-1 was observed, suggesting that T-cell epitopes outside of this region may provide the necessary cognate help for specific antibody production.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254580      PMCID: PMC98152          DOI: 10.1128/IAI.69.4.2245-2251.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  A single amino acid determines the specificity of a monoclonal antibody which inhibits Plasmodium chabaudi AS in vivo.

Authors:  P G McKean; K O'Dea; K N Brown
Journal:  Mol Biochem Parasitol       Date:  1993-12       Impact factor: 1.759

2.  A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice.

Authors:  T M Daly; C A Long
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

3.  Cellular and humoral immune responses to well-defined blood stage antigens (major merozoite surface antigen) of Plasmodium falciparum in adults from an Indian zone where malaria is endemic.

Authors:  L Kabilan; V P Sharma; P Kaur; S K Ghosh; R S Yadav; V S Chauhan
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

4.  Differential induction of helper T cell subsets during blood-stage Plasmodium chabaudi AS infection in resistant and susceptible mice.

Authors:  M M Stevenson; M F Tam
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

5.  Altered response of CD4+ T cell subsets to Plasmodium chabaudi chabaudi in B cell-deficient mice.

Authors:  T von der Weid; J Langhorne
Journal:  Int Immunol       Date:  1993-10       Impact factor: 4.823

6.  Nucleotide sequence analysis and epitope mapping of the merozoite surface protein 1 from Plasmodium chabaudi chabaudi AS.

Authors:  P G McKean; K O'Dea; K N Brown
Journal:  Mol Biochem Parasitol       Date:  1993-12       Impact factor: 1.759

7.  Solution structure of an EGF module pair from the Plasmodium falciparum merozoite surface protein 1.

Authors:  W D Morgan; B Birdsall; T A Frenkiel; M G Gradwell; P A Burghaus; S E Syed; C Uthaipibull; A A Holder; J Feeney
Journal:  J Mol Biol       Date:  1999-05-28       Impact factor: 5.469

8.  Processing of the Plasmodium falciparum major merozoite surface protein-1: identification of a 33-kilodalton secondary processing product which is shed prior to erythrocyte invasion.

Authors:  M J Blackman; H Whittle; A A Holder
Journal:  Mol Biochem Parasitol       Date:  1991-11       Impact factor: 1.759

9.  Immunization against malaria with a recombinant protein.

Authors:  I T Ling; S A Ogun; A A Holder
Journal:  Parasite Immunol       Date:  1994-02       Impact factor: 2.280

10.  Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein.

Authors:  M J Blackman; T J Scott-Finnigan; S Shai; A A Holder
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more
  16 in total

1.  An engineered Plasmodium falciparum C-terminal 19-kilodalton merozoite surface protein 1 vaccine candidate induces high levels of interferon-gamma production associated with cellular immune responses to specific peptide sequences in Gambian adults naturally exposed to malaria.

Authors:  C Bisseye; L M Yindom; J Simporé; W D Morgan; A A Holder; J Ismaili
Journal:  Clin Exp Immunol       Date:  2011-12       Impact factor: 4.330

2.  Competition and the evolution of reproductive restraint in malaria parasites.

Authors:  Laura C Pollitt; Nicole Mideo; Damien R Drew; Petra Schneider; Nick Colegrave; Sarah E Reece
Journal:  Am Nat       Date:  2011-03       Impact factor: 3.926

3.  Regulation of antigen-specific immunoglobulin G subclasses in response to conserved and polymorphic Plasmodium falciparum antigens in an in vitro model.

Authors:  Olivier Garraud; Ronald Perraut; Ababacar Diouf; Wilfrid S Nambei; Adama Tall; André Spiegel; Shirley Longacre; David C Kaslow; Hélène Jouin; Denise Mattei; Gina M Engler; Thomas B Nutman; Eleanor M Riley; Odile Mercereau-Puijalon
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

4.  Effector memory Th1 CD4 T cells are maintained in a mouse model of chronic malaria.

Authors:  Robin Stephens; Jean Langhorne
Journal:  PLoS Pathog       Date:  2010-11-24       Impact factor: 6.823

5.  Evaluation of recombinant Plasmodium knowlesi merozoite surface protein-1(33) for detection of human malaria.

Authors:  Fei Wen Cheong; Yee Ling Lau; Mun Yik Fong; Rohela Mahmud
Journal:  Am J Trop Med Hyg       Date:  2013-03-18       Impact factor: 2.345

Review 6.  Using two phases of the CD4 T cell response to blood-stage murine malaria to understand regulation of systemic immunity and placental pathology in Plasmodium falciparum infection.

Authors:  Komi Gbedande; Victor H Carpio; Robin Stephens
Journal:  Immunol Rev       Date:  2020-01       Impact factor: 12.988

7.  Cellular responses to modified Plasmodium falciparum MSP119 antigens in individuals previously exposed to natural malaria infection.

Authors:  Christian M F Okafor; Chiaka I Anumudu; Yusuf O Omosun; Chairat Uthaipibull; Idowu Ayede; Henrietta O Awobode; Alex B Odaibo; Jean Langhorne; Anthony A Holder; Roseangela I Nwuba; Marita Troye-Blomberg
Journal:  Malar J       Date:  2009-11-23       Impact factor: 2.979

8.  Cytokine responses of CD4+ T cells during a Plasmodium chabaudi chabaudi (ER) blood-stage infection in mice initiated by the natural route of infection.

Authors:  Luis Fonseca; Elsa Seixas; Geoffrey Butcher; Jean Langhorne
Journal:  Malar J       Date:  2007-06-07       Impact factor: 2.979

9.  Functional memory B cells and long-lived plasma cells are generated after a single Plasmodium chabaudi infection in mice.

Authors:  Francis Maina Ndungu; Emma Tamsin Cadman; Joshua Coulcher; Eunice Nduati; Elisabeth Couper; Douglas William Macdonald; Dorothy Ng; Jean Langhorne
Journal:  PLoS Pathog       Date:  2009-12-11       Impact factor: 6.823

10.  Disruption of IL-21 signaling affects T cell-B cell interactions and abrogates protective humoral immunity to malaria.

Authors:  Damián Pérez-Mazliah; Dorothy Hui Lin Ng; Ana Paula Freitas do Rosário; Sarah McLaughlin; Béatris Mastelic-Gavillet; Jan Sodenkamp; Garikai Kushinga; Jean Langhorne
Journal:  PLoS Pathog       Date:  2015-03-12       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.